PhaseBio Pharmaceuticals Details
PhaseBio is a biopharmaceutical firm that researches and develops novel therapeutics for the treatment of orphan diseases.
Employees:
100 - 249
HQ:
610-981-6500
Location:
Malvern, PA, US
Revenue:
10 - 20 Million
Elastin-like polypeptide biopolymer
improved biotherapeutics
phase transition
slow absorption
Orphan diseases
cardiopulmonary disorders
DMD cardiomyopathy
Pulmonary Arterial Hypertension
Heart failure
Vasoactive Intestinal Peptide
Ticagrelor reversal agent
B2B
B2C
BioTech/Drugs
Commercial Physical Research
Biotechnology